Sana Biotechnology, Inc. ( SANA) - Key Metrics
SANA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.22 | -$0.11 | -$0.12 |
| 2026Q1 | $0 | -$0.17 | -$0.14 | -$0.14 |
| 2025Q4 | $0 | -$0.23 | -$0.13 | -$0.13 |
| 2025Q3 | $0 | -$0.16 | -$0.11 | -$0.11 |
| 2025Q2 | $0 | -$0.39 | -$0.14 | -$0.14 |
SANA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.97 |
| 2026Q1 | 0% | -4.24 |
| 2025Q4 | 0% | -4.85 |
| 2025Q3 | 0% | -5.55 |
| 2025Q2 | 0% | -1.75 |
SANA
Price: $3.55
52 week price:
Earnings Per Share: -0.75 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.2 million
Market Capitalization: 1.1 billion